Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Monitoring brain activity in patients with severe seizures

Official title: The Use of Continuous Electroencephalographic (EEG) Monitoring for Cases of Refractory Status Epilepticus: Does it Affect the Final Patient Outcome

Run by Barts & The London NHS Trust · NCT04170491 · Data updated 2026-11-12

This study is testing if continuous brain monitoring can help improve recovery and outcomes for patients with severe seizures in the ICU compared to standard care.

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment40 (estimated)
SponsorBarts & The London NHS Trust
Academic / other
Locations1 site (London)
StatusRecruiting
StartedMarch 17, 2020
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT04170491 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients over 16 years old diagnosed with refractory status epilepticus who have not responded to initial treatments.

Probably not a fit

Patients with anoxic brain injury will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of continuous electroencephalogram (cEEG) monitoring in patients with refractory status epilepticus (RSE) in an intensive care unit setting. Patients will be randomly assigned to receive either standard medical care or cEEG monitoring, which will continue for 24 hours after seizure activity ceases. The study aims to assess whether cEEG can improve patient outcomes, including reduced hospital stay, lower mortality rates, and enhanced quality of life post-discharge. Data will be collected from patient medical records to evaluate the impact of cEEG on clinical outcomes compared to standard care.

Why it matters

Potential benefit: If successful, this approach could lead to improved management and outcomes for patients suffering from refractory status epilepticus.

How similar studies have gone: There is currently no available data from previous studies assessing the impact of continuous EEG on clinical outcomes in patients with refractory status epilepticus, making this approach novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Patients aged \> 16 years

  * Consent obtained according to Mental Capacity Act 2005
  * Patients admitted to ICU for treatment of status epilepticus or admitted for another reason and diagnosed with SE during their admission
  * Convulsive Status epilepticus defined by either:

    * Tonic-clonic SE lasting longer than 5 minutes,
    * Focal SE with impaired consciousness lasting longer than 10 minutes
    * or Non-Convulsive SE according to Salzburg consensus criteria
  * Status epilepticus that continues despite treatment with benzodiazepine and one antiepileptic medication

Exclusion Criteria:

* Anoxic brain injury

Where it's running

  • Royal London Hospital
    London, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Recovery after coma from serious brain injury or illness

    This observational study will follow adults who are unconscious due to a serious brain illness or injury to see what medical, neurological, psychological, and social factors are linked with recovery over time.

    Recruiting University of California, San Francisco · San Francisco, California · NCT07614074

  • Augmented kidney clearance in neurocritical care

    This project will test whether adults in the neuro-ICU with severe brain injury, stroke, seizures, or brain infections have faster kidney clearance (ARC) that can lower antiseizure and antibiotic drug levels.

    Recruiting at 3 sites University of Alberta · Lexington, Kentucky and 2 other locations · NCT07410624

  • Ketamine added to levetiracetam to stop prolonged convulsive seizures

    This trial will test whether giving ketamine (two different doses) along with levetiracetam helps stop benzodiazepine-refractory status epilepticus in people age 1 and older.

    Recruiting at 36 sites Phase 3 University of Virginia · Birmingham, Alabama and 62 other locations · NCT06907173

  • Improving prognosis for patients with Status Epilepticus

    This study is trying to find blood markers that can help predict how well patients with Status Epilepticus will recover in the ICU and how their thinking skills may change after they leave the hospital.

    Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT06590883

  • Using Rapid-Response EEG to Diagnose Seizures in Children

    This study is testing if a new quick EEG device can help doctors diagnose seizures in children faster than the standard method.

    Recruiting Children's Hospital at Montefiore · The Bronx, New York · NCT06564662

  • Two-way video support for paramedics caring for infants with life-threatening breathing problems.

    This project will test whether a two-way video link with pediatric emergency doctors helps paramedics give better care to infants with life-threatening breathing problems during transport.

    Recruiting at 4 sites Boston Medical Center · Los Angeles, California and 8 other locations · NCT06441760

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.